USP3 and neuroblastoma: Silencing endogenous USP3 with USP3 siRNA-1 or USP3 siRNA-2 (lanes 2–3 and 5–6, Fig. 7a) in MYCN-amplified neuroblastoma cells significantly decreased MYCN protein expression (Fig. 7a).